The emergence of the novel coronavirus pneumonia (COVID-19) pandemic at the end of 2019 led to worldwide chaos. However, the world breathed a sigh of relief when a few countries announced the development of a vaccine and gradually began to distribute it. Nevertheless, the emergence of another wave of this pandemic returned us to the starting point. At present, early detection of infected people is the paramount concern of both specialists and health researchers. This paper proposes a method to detect infected patients through chest x-ray images by using the large dataset available online for COVID-19 (COVIDx), which consists of 2128 X-ray images of COVID-19 cases, 8,066 normal cases, and 5,575 cases of pneumonia. A hybrid algorithm is applied to improve image quality before undertaking neural network training. This algorithm combines two different noise-reduction filters in the image, followed by a contrast enhancement algorithm. To detect COVID-19, we propose a novel convolution neural network (CNN) architecture called KL-MOB (COVID-19 detection network based on the MobileNet structure). The performance of KL-MOB is boosted by adding the Kullback-Leibler (KL) divergence loss function when trained from scratch. The KL divergence loss function is adopted for content-based image retrieval and fine-grained classification to improve the quality of image representation. The results are impressive: the overall benchmark accuracy, sensitivity, specificity, and precision are 98.7%, 98.32%, 98.82% and 98.37%, respectively. These promising results should help other researchers develop innovative methods to aid specialists. The tremendous potential of the method proposed herein can also be used to detect COVID-19 quickly and safely in patients throughout the world.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459788 | PMC |
http://dx.doi.org/10.7717/peerj-cs.694 | DOI Listing |
Cancer Imaging
January 2025
Department of Radiology, Chongqing University Cancer Hospital, Chongqing, China.
Background: Previous studies utilizing dual-energy CT (DECT) for evaluating treatment efficacy in nasopharyngeal cancinoma (NPC) are limited. This study aimed to investigate whether the parameters from DECT can predict the response to induction chemotherapy in NPC patients in two centers.
Methods: This two-center retrospective study included patients diagnosed with NPC who underwent contrast-enhanced DECT between March 2019 and November 2023.
Fluids Barriers CNS
January 2025
Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven - University of Leuven, O&N II Herestraat 49 box 820, 3000, Leuven, Belgium.
Background: Therapeutic antibodies for the treatment of neurological disease show great potential, but their applications are rather limited due to limited brain exposure. The most well-studied approach to enhance brain influx of protein therapeutics, is receptor-mediated transcytosis (RMT) by targeting nutrient receptors to shuttle protein therapeutics over the blood-brain barrier (BBB) along with their endogenous cargos. While higher brain exposure is achieved with RMT, the timeframe is short due to rather fast brain clearance.
View Article and Find Full Text PDFArthritis Res Ther
January 2025
Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum, Herne, Germany.
Background: Optical spectral transmission (OST) is a modern diagnostic method capable of quantifying inflammation in the finger and wrist joints of arthritis patients by assessing the blood-specific absorption of light transmitted through a tissue. The diagnostic performance of this modality has not been adequately examined and data regarding OST associations with magnetic resonance imaging (MRI) are limited. Aim of this study was therefore to investigate the performance of OST in assessing joint inflammation as compared to MRI in patients with inflammatory arthritis (IA).
View Article and Find Full Text PDFBMC Med Imaging
January 2025
Department of Pathology, Dr. Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Purpose: To evaluate the staging performance of positron emission tomography/magnetic resonance imaging (PET/MRI) for confirmed esophageal cancer based on the TNM classification system as well as compare it to other alternative modalities (e.g., endoscopic ultrasonography (EUS), computed tomography (CT), MRI, and PET/CT) in a full head-to-head manner.
View Article and Find Full Text PDFNat Cancer
January 2025
AstraZeneca, Gaithersburg, MD, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!